Clinical trials
24 active studies led by Biocad, of 94 in all
Source: ClinicalTrials.gov, Studies with Biocad (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Biocad in 4 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Biocad or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
24 active studies led by Biocad, of 94 in all
Source: ClinicalTrials.gov, Studies with Biocad (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Biocad leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Biocad or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Biocad: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Biocad is in.
Stories on the topics Biocad works in.
More than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful…
Read
Gut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or…
Read
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read